ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 19, 2017 | $75,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 24, 2019 | $75,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
n/a
Foreign entity interest: C-THRU S637 HR 1316 Prescription Drug Price Transparency Act Part B Part D Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Vice President, Advocacy and Access |
| VINCENT PACILEO | Director, Federal Affairs |
Health Issues HCR
American Health Care Act (H.R. 1628) BCRA (Better Care Reconciliation Act) S989 Ensuring Childrens Access to Specialty Care Act HR 2999 Patients Access to Treatments Act HR 2077 Restoring the Patients Voice Act HR 2430, S 934 FDA Reauthorization Act HR 1703, Medical Product Communications Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Vice President, Advocacy and Access |
| VINCENT PACILEO | Director, Federal Affairs |
Budget/Appropriations BUD
Budget Control Act FY17 Appropriations for HHS FY17 Appropriations for DoD FY17 Appropriations for VA FY18 Appropriations for DoD FY18 Appropriations for HHS FY18 Appropriations for VA Bipartisan Budget Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Vice President, Advocacy and Access |
| VINCENT PACILEO | Director, Federal Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.